Connect with us

Hi, what are you looking for?

(The Center Square) – The U.S. Food and Drug Administration on Friday granted approval for the Pfizer-BioNTech’s COVID-19 vaccine to be administered to children ages 5 to 11.

Earlier this week, an FDA advisory committee recommended the vaccine be approved for the age group. 

“The FDA has determined this Pfizer vaccine has met the criteria for emergency use authorization,” the agency said in a news release. “Based on the totality of scientific evidence available, the known and potential benefits of the Pfizer-BioNTech COVID-19 vaccine in individuals down to 5 years of age outweigh the known and potential risks.”

The vaccine given to children ages 5 to 11 will be one-third the dose approved for those 12 and older.

The U.S. Centers for Disease Control and Prevention must still give its authorization before the age group can begin receiving the vaccine. That approval is expected next week.

The Georgia Virtue
Written By

Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.

Advertisement
Advertisement

Facebook

The Georgia Virtue on Youtube

Advertisement

You May Also Like

Bulloch Local News

The Ogeechee Judicial Circuit District Attorney’s Office was dealt another blow by jurors this week after they sided with defense attorneys in a 2020...

Bulloch Crime & Safety

1:30 PM – This update clarifies a previous version of the story, which indicated an arrest. Ebleng appeared in Monday’s booking report from the...

Bulloch Crime & Safety

These jail records are matters of public record provided by the Bulloch County Sheriff’s Office. Booking reports are details of arrests only. All persons...

Bulloch Crime & Safety

These jail records are matters of public record provided by the Bulloch County Sheriff’s Office. Booking reports are details of arrests only. All persons...

Copyright © 2021 ... JustSun LLC.

NEVER MISS A STORY!
Sign Up For Our  Newsletter
Get the latest headlines and stories - and even exclusive content!- sent right to your inbox.
Stay Updated
Give it a try, you can unsubscribe anytime.
close-link